C-BRAIN
Welcome to the Consortium for
Biomedical Research & AI
in Neurodegeneration
OUR MISSION
To design and implement AI as a collaborative partner for scientists, accelerating discovery in neurodegeneration research to improve human health.
Three Pillars
of the AI Biomedical Research Scientist
The Consortium for Biomedical Research and AI in Neurodegeneration (C-BRAIN) introduces the AI Biomedical Research Scientist Initiative. This diagram illustrates the three crucial factors driving this revolution:
Advanced AI Technologies
Unprecedented volumes of actionable biomedical data
World-class scientific expertise to curate and train AI systems
Launch Announcement | August 25, 2025
Consortium for Biomedical Research and AI in Neurodegeneration (C-BRAIN) Launches July 30, 2025
Alzforum’s latest community news, AI Biomedical Scientist in Its Sights, C-brAIn Gets Going, highlights an exciting breakthrough where AI is leveraged to decode the neural circuitry of the C. elegans brain. This pioneering approach promises to enhance our understanding of fundamental neurological processes and offers potential implications for the future of biomedical research and the treatment of neurological disorders.
C-BRAIN – A pioneering initiative in AI-driven discovery
PDF | July 30, 2025
Publication
Andrieu S, Bateman RJ, Bereczki E, Bose N, Brookes AJ, Doraiswamy PM, Kivipelto M, Kohlhaas S, Kourtis L, Middleton LT, Moore GJ, Petrella JR, Postlethwaite N, Sainz-Fuertes R. Harnessing artificial intelligence to transform Alzheimer’s disease research. Nat Med. 2025 Apr 1; Epub 2025 Apr 1 PubMed.
Major Contributing Members
Alzforum
AD Data Initiative
Alzheimer’s Association
Bristol Myers Squibb
Gates Ventures
Rainwater Charitable Foundation
Sage Bionetworks
Sanofi
The Dolby Family
The 10,000 Brains Project
The Robertson Foundation
Washington University in St. Louis
Key Members
Eisai
Johnson & Johnson
Join Our Consortium
Interested in advancing biomedical research?
Fill out our survey to learn more about joining the C-brAIn Consortium
and contribute to groundbreaking discoveries in neurodegeneration.